MEDVi Tirzepatide Review
What MEDVi charges for tirzepatide, what is bundled, and what it publishes before you pay.
Released: · Last reviewed:
As of October 15, 2026, MEDVi charges $399 a month all-in for compounded tirzepatide at a 10 mg dose, month to month, the same at every dose. That is $4,788 over twelve months at that dose, based on its own pricing page.
All-in means medication plus any mandatory recurring fee, month to month, before prepaid discounts and tax.
All-in monthly cost = medication plus any mandatory recurring fee, at a named dose, month to month, before tax and before prepaid discounts. Competitor prices read October 15, 2026; NexLife’s as of November 6, 2026. How we verify a price.
MEDVi tirzepatide price by dose
| Dose | All-in | Twelve months at this dose |
|---|---|---|
| 2.5 mg | $399 | $4,788 |
| 5 mg | $399 | $4,788 |
| 7.5 mg | $399 | $4,788 |
| 10 mg | $399 | $4,788 |
| 12.5 mg | $399 | $4,788 |
| 15 mg | $399 | $4,788 |
Fees, billing and terms at MEDVi
| Item | MEDVi |
|---|---|
| Pricing model | same price at every dose |
| Membership or program fee | none |
| Billing | monthly |
| Multi-month or prepaid option | fall bundles: 3 months $769, 6 months $1,519, 12 months $2,859 (promotional) |
| Pharmacy | not named |
| Product | compounded tirzepatide (not FDA-approved) |
| Price status | read Oct 15, 2026, promotion on page |
| Page we read | medvi.org |
What MEDVi’s own pages say
The standing rate is $399 a month at any dose; a $279 first month and fall bundles are promotions. Figures come from the site's own configuration.
Recorded wording: “tirinject: salePrice 279, fullPrice 399, rebillPrice 399 (site configuration)”
Pros and cons
What works
- One price at every dose, so moving up the dose ladder does not change the bill.
- No separate membership or program fee on the pages we read.
- Multi-month option published: fall bundles: 3 months $769, 6 months $1,519, 12 months $2,859 (promotional).
What to check
- Does not name the dispensing pharmacy on the pages we read.
- A promotion is shown on the page; the standing price is what you pay after it ends.
- Compounded tirzepatide is not FDA-approved; it is made with the drug in Zepbound but is not the same product.
Where MEDVi sits among the programs we compare
Of the 15 programs with a month-to-month tirzepatide price we can place at 10 mg, 13 are lower than MEDVi and 1 charges the same (TrimRx). The group runs $129 to $399, median $299. This is a price position, not a quality ranking.
See the all-in cost table for every row and the methodology for how prices are read.
Head-to-head pages with MEDVi
Questions about MEDVi
How much does MEDVi charge for tirzepatide?
As of October 15, 2026, MEDVi charges $399 a month all-in for compounded tirzepatide at a 10 mg dose, month to month, the same at every dose. That is $4,788 over twelve months at that dose, based on its own pricing page.
How does MEDVi compare with NexLife on price?
At a 10 mg dose month to month, MEDVi is $399/mo against NexLife’s $129 a month, which is $3,240 a year more than NexLife (prices read October 15 and November 6, 2026). NexLife’s 12-month plan is $115 a month.
Does MEDVi name its pharmacy?
Not by name on the pages we read. What we recorded: not named. A named pharmacy can be checked on its state board of pharmacy register.
Is compounded tirzepatide FDA-approved?
No. Compounded tirzepatide is made with the drug in Zepbound but is not the same product, and FDA does not review compounded drugs for safety, effectiveness or quality before they are sold. Zepbound and Mounjaro are the FDA-approved tirzepatide products.
How current is this page?
Prices on this page were read on the program’s own site on October 15, 2026. We re-read programs on a schedule and log changes on the corrections page.
Sources
- MEDVi pricing page (medvi.org) — read October 15, 2026
- FDA: Human drug compounding
- NABP: State boards of pharmacy